Antidepressant use and risk of intubation or death in hospitalized patients with COVID-19: A retrospective cohort study of clinical effectiveness

Initial controlled trials of the serotonergic antidepressant fluvoxamine showed promise for treatment of mild to moderate COVID-19 in outpatients, although more recent outpatient data have been less encouraging. Turning to studies of hospitalized patients, a retrospective cohort study by Hoertel and...

Descripción completa

Detalles Bibliográficos
Autores principales: Brennan, Brian P., Schnabel, Jiana, Pope, Harrison G., Hudson, James I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520125/
https://www.ncbi.nlm.nih.gov/pubmed/36186877
http://dx.doi.org/10.3389/fpsyt.2022.951065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520125/
https://www.ncbi.nlm.nih.gov/pubmed/36186877
http://dx.doi.org/10.3389/fpsyt.2022.951065

Ejemplares similares